PSY-0.6

PSY-0.6 is a specific formulation of **psilocybin**, a naturally occurring psychedelic compound found in certain mushrooms, developed by Revive Therapeutics as part of their proprietary **PSY** series of delivery formats for psychiatric and neurological indications. It acts primarily as a **serotonin 2A receptor agonist**, inducing altered states of consciousness that promote neuroplasticity and emotional processing, with potential applications in treatment-resistant depression, anxiety, PTSD, and addiction. The **0.6** designation likely indicates a dose strength (e.g., 0.6 mg or a related formulation variant), distinguishing it from other formats like capsules (PSY-0.1) or sublingual spray, though specific clinical data on this exact variant remains limited.[13]